Immediate Impact
5 standout
Citing Papers
New epilepsy therapies in development
2024 Standout
Antiseizure Medications for Adults With Epilepsy
2022 Standout
Works of Perminder Bhatia being referenced
Post hoc analysis of a phase 3, multicenter, open‐label study of cenobamate for treatment of uncontrolled focal seizures: Effects of dose adjustments of concomitant antiseizure medications
2021
Efficacy and safety of conversion to monotherapy with eslicarbazepine acetate in adults with uncontrolled partial-onset seizures: a historical-control phase III study
2015
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Perminder Bhatia | 121 | 91 | 103 | 5 | 127 | |
| Edoardo Ferlazzo | 94 | 30 | 73 | 5 | 111 | |
| Ugo Leggio | 175 | 102 | 113 | 7 | 204 | |
| Deborah T Combs Cantrell | 186 | 38 | 95 | 5 | 212 | |
| Dulce Campos | 130 | 53 | 108 | 9 | 134 | |
| C. Ciampa | 132 | 47 | 116 | 9 | 202 | |
| Sophie von Brauchitsch | 68 | 37 | 52 | 5 | 105 | |
| P. Giner | 123 | 51 | 112 | 6 | 135 | |
| Kandan Kulandaivel | 47 | 35 | 39 | 5 | 88 | |
| Guntis Rozentals | 68 | 39 | 57 | 3 | 85 | |
| Srishti Nangia | 110 | 41 | 63 | 11 | 175 |
All Works
Login with ORCID to disown or claim papers
Loading papers...